
01 October 2026Event
Brussels HLS Day
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition
ECCTA is a wide-ranging piece of legislation, addressing a number of issues, but broadly themed around measures to prevent financial crime and to promote transparency in the ownership and use of corporate structures. It contains diverse and unrelated provisions, some of which came into force immediately in December 2023, while others will be brought into force throughout 2024 and into 2025.
Companies and partnerships will need to take steps to address some of what ECCTA brings immediately, while other changes cannot effectively be addressed until they are clarified by secondary legislation or government guidance.
This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.
If you have any questions, contact a member of the Economic Crime and Corporate Transparency Act team for assistance:

01 October 2026Event
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition

02 July 2026 Event
Join our upcoming event that will feature speakers from J.P. Morgan, Bank of America, and Simmons & Simmons
22 June 2026 News Article
Nous avons conseillé Copy-Sud, filiale du groupe Orians, leader dans son secteur dédié à la transformation numérique, lors de l’acquisition du groupe Ynov’IT.
19 June 2026 News Article
Our German Real Estate team has advised Scannell Properties on acquiring a 23,000 sq m brownfield site in Hockenheim for a strategic logistics project.

16 June 2026 Publication
On 4 June 2026, the Court of Justice of the European Union (CJEU) issued its judgment in Case C 10/24 Dürr Dental SE v Cattani Deutschland Helmes GmbH & Co. KG